Both in Pharmaceuticals
Indaptus Therapeutics vs Altimmune
Over the past year INDP returned −1.0% and ALT returned −48.5%; their daily moves had a correlation of 0.05.
INDP −1.0% ALT −48.5%Growth of $1, one year, split-adjusted
| Metric | INDP | ALT |
|---|---|---|
| Price | $3.09 | $2.04 |
| Market cap | $411.7M | $396.8M |
| Today | −7.49% | −4.67% |
| 1 month | +45.8% | −26.1% |
| 6 months | +44.4% | −27.7% |
| Year to date | +6.2% | −43.5% |
| 1 year | −7.5% | −49.0% |
| Revenue growth (YoY) | — | −100.0% |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | — | 12,800.5× |
| Net cash | $11.6M | $291.5M |
| Dividend yield | — | — |
| Volatility (60d) | 191.8% | 47.2% |
| Short % of float | 7.4% | 22.2% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).